Nutritional assessment and support of the patient with acute heart failure

被引:13
作者
Sarma, Satyam [1 ]
Gheorghiade, Mihai [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Dept Med,Ctr Cardiovasc Qual & Outcomes, Chicago, IL 60611 USA
关键词
cardiac cachexia; carnitine; nutrition in heart failure; omega-3 fatty acids; thiamine; LEFT-VENTRICULAR FUNCTION; L-CARNITINE; HOSPITALIZED-PATIENTS; THIAMINE-DEFICIENCY; ENTERAL NUTRITION; ELDERLY-PATIENTS; NUTRIENT INTAKE; THERAPY; PREVALENCE; SURVIVAL;
D O I
10.1097/MCC.0b013e32833e10d4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose of review A significant number of patients hospitalized with heart failure are malnourished. Depletion of micronutrients, which is known to occur in heart failure for a variety of reasons, may contribute to myocardial abnormalities noted in heart failure. In this review, we focus on nutritional supplementation strategies that might improve myocardial performance and, as a consequence, decrease mortality and morbidity in these patients. Recent findings The available data suggest that micronutrient and macronutrient supplementation may play a role in improving the myocardial metabolic abnormalities noted in heart failure. A recent trial of omega-3 fatty acid macronutrient supplementation showed a modest decrease in mortality and hospitalizations when used in patients with New York Heart Association class II-IV heart failure. Summary Recommendations for nutritional support in patients with heart failure are difficult to make due to a lack of large randomized trials. Supplementation with omega-3 fatty acids, and micronutrients such as thiamine, coenzyme Q-10 and carnitine has shown promise in several studies. Since the data is not conclusive, large trials are needed to address whether these positive findings are reproducible in a wider subset of patients. In addition, these trials should study the combination of different micronutrients and macronutrients since heart failure patients are rarely deficient in just one micronutrient or macronutrient.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 44 条
[1]   Cardiac cachexia - A syndrome with impaired survival and immune and neuroendocrine activation [J].
Anker, SD ;
Coats, AJS .
CHEST, 1999, 115 (03) :836-847
[2]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[3]   Is nutritional intake adequate in chronic heart failure patients? [J].
Aquilani, R ;
Opasich, C ;
Verri, M ;
Boschi, F ;
Febo, O ;
Pasini, E ;
Pastoris, O .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1218-1223
[4]   Nutritional Inadequacies in Patients with Stable Heart Failure [J].
Arcand, Joanne ;
Floras, Vanessa ;
Ahmed, Mavra ;
Al-Hesayen, Abdul ;
Ivanov, Joan ;
Allard, Johane P. ;
Newton, Gary E. .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2009, 109 (11) :1909-1913
[5]   Carnitine and its derivatives in cardiovascular disease [J].
Arsenian, MA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (03) :265-286
[6]   Enteral Nutrition and Cardiovascular Failure: From Myths to Clinical Practice [J].
Berger, Mette M. ;
Chiolero, Rene L. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2009, 33 (06) :702-709
[7]   NUTRITIONAL ASSESSMENT AND MUSCLE ENERGY-METABOLISM IN SEVERE CHRONIC CONGESTIVE-HEART-FAILURE - EFFECTS OF LONG-TERM DIETARY SUPPLEMENTATION [J].
BROQVIST, M ;
ARNQVIST, H ;
DAHLSTROM, U ;
LARSSON, J ;
NYLANDER, E ;
PERMERT, J .
EUROPEAN HEART JOURNAL, 1994, 15 (12) :1641-1650
[8]   PREVALENCE AND HEMODYNAMIC CORRELATES OF MALNUTRITION IN SEVERE CONGESTIVE HEART-FAILURE SECONDARY TO ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY [J].
CARR, JG ;
STEVENSON, LW ;
WALDEN, JA ;
HEBER, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (11) :709-713
[9]   Nutrient intake and serum cytokine pattern in elderly people with heart failure [J].
Catapano, Girolamo ;
Pedone, Claudio ;
Nunziata, Eleonora ;
Zizzo, Alessandro ;
Passantino, Andrea ;
Incalzi, Raffaele Antonelli .
EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (04) :428-434
[10]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140